Somatostatin inhibition of insulin secretion in insulin-producing tumors
- 1 June 1976
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 25 (6) , 603-609
- https://doi.org/10.1016/0026-0495(76)90056-1
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- SOMATOSTATIN AND INSULINOMAThe Lancet, 1975
- Somatostatin Inhibition of Insulin and Gastrin Hypersecretion in Pancreatic Islet-Cell CarcinomaNew England Journal of Medicine, 1975
- FAILURE OF SOMATOSTATIN TO INHIBIT TOLBUTAMIDE-INDUCED INSULIN SECRETION IN PATIENTS WITH INSULINOMAS: A POSSIBLE DIAGNOSTIC TOOLJournal of Clinical Endocrinology & Metabolism, 1975
- Effect of Somatostatin on Plasma Glucose and Insulin Responses to Glucagon and Tolbutamide in ManJournal of Clinical Endocrinology & Metabolism, 1974
- Effect of somatostatin on blood glucose, plasma growth hormone, insulin, and free fatty acids in normal subjects and acromegalic patientsMetabolism, 1974
- Inhibition of Pancreatic Glucagon Responses to Arginine by Somatostatin in Normal Man and in Insulin-Dependent DiabeticsDiabetes, 1974
- Somatostatin: Newcomer from the HypothalamusNew England Journal of Medicine, 1974
- INHIBITION OF INSULIN SECRETION BY SOMATOSTATINThe Lancet, 1973
- Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth HormoneScience, 1973
- Immunoassay of insulin with insulin-antibody precipitateBiochemical Journal, 1963